HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

phoslactomycin A

structure given in first source; isolated from Streptomyces nigrescens SC-273

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - phoslactomycin A: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Pyrones: 35
      - phoslactomycin A: 1

Experts

1.	Amemiya, Masahide: 1 article (02/2003)
2.	Ishizuka, Masaaki: 1 article (02/2003)
3.	Kawada, Manabu: 1 article (02/2003)
4.	Kawatsu, Masaji: 1 article (02/2003)
5.	Kohama, Takafumi: 1 article (02/2003)
6.	Masuda, Tohru: 1 article (02/2003)
7.	Ohba, Shun-ichi: 1 article (02/2003)
8.	Takeuchi, Tomio: 1 article (02/2003)

Related Diseases

1.	Neoplasm Metastasis (Metastasis) 02/01/2003 - "Phoslactomycin A and leustroducsin H, other specific inhibitors of PP2A, also augmented NK cell activity and inhibited lung metastasis, but a CTS analogue without inhibitory activity on PP2A and calyculin A, a dual inhibitor of PP1 and PP2A, did not. "

Related Drugs and Biologics

1.	leustroducsin H
2.	calyculin A